RxDoctor Payments Data

Ashley Plant

Pediatric Hematology-Oncology · Chicago, ILNPI 1295050763

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,500 of the $1,681 with a category attached, or 89.2%. E.r. Squibb & Sons, L.L.C. accounts for 89.2% of it on its own, with 4 other manufacturers making up the rest.

$1,681in general payments, 2019–2025

Across 10 payments — averaging $168.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$2K
  • Servier Pharmaceuticals LLC$104
  • Jazz Pharmaceuticals Inc.$45
  • Amgen$19
  • BTG International Inc.$14
$1,144,076in research payments, 2019–2025

Across 30 payments — averaging $38,136 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$859K
  • PTC Therapeutics, Inc.$178K
  • Blueprint Medicines Corporation$97K
  • Boehringer Ingelheim$10K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$168

What the payments were for

  • Consulting fees$1,50089%
  • Food & beverage$18111%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,681 in reported general payments places this provider in the 65th percentile of 78 pediatric hematology-oncology providers in Illinois.

See all pediatric hematology-oncology providers in Illinois

Other pediatric hematology-oncology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →